Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels.

Abstract

The use of toxins for cancer therapy has great promise. Gelonin, a potent plant toxin, causes cell death by inactivating the 60S ribosomal subunit. Recently, we developed a novel gene delivery system using biodegradable cationic heparin-polyethyleneimine (HPEI) nanogels. In the current study, the antitumor activity of a recombinant plasmid expressing gelonin (pGelonin) on human ovarian cancer was assessed. The application of HPEI nanogels, was also evaluated. Gelonin-cDNA was cloned into the pVAX1 plasmid vector and transfected into SKOV3 human ovarian cancer cells using biodegradable cationic HPEI nanogels. The expression of gelonin in vitro and in vivo was confirmed using RT-PCR and western blot analysis. Cell viability and apoptosis were examined using an MTT assay and flow cytometric analysis. For the in vivo study, an SKOV3 intraperitoneal ovarian carcinomatosis model was established, and nude mice were randomly assigned into four groups receiving i.p. administration of pGelonin/HPEI complexes, pVAX/HPEI complexes, HPEI alone and 5% glucose solution. The tumor weight was monitored, and a TUNEL assay and Ki-67 immunohistochemistry were performed to evaluate apoptosis and cell proliferation in the tumor tissue sections, respectively. Gelonin was efficiently expressed in SKOV3 cancer cells in vitro and in vivo using pGelonin incorporated with HPEI nanogels. The pGelonin/HPEI complexes inhibited cell viability and induced apoptosis in the cell culture. Treatment for intraperitoneal carcinomatosis with pGelonin/HPEI complexes reduced the tumor weight by ~58.55% compared to the control groups (P<0.05). The antitumor effect was accompanied by increased apoptosis and reduced cell proliferation (P<0.05). No significant side effects were observed with i.p. administration of the pGelonin/HPEI complexes. Our data indicate that HPEI nanogel-delivered pGelonin may have promising applications against human ovarian cancer.

• Authors: Yu Bai, Maling Gou, Tao Yi, Li Yang, Lili Liu, Xiaojuan Lin, Dan Su, Yuquan Wei, Xia Zhao
• Journal: International journal of medical sciences (Int J Med Sci) Vol. 12 Issue 5 Pg. 397-406 ( 2015) ISSN: 1449-1907 [Electronic] Australia
• PMID: 26005374 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Biocompatible Materials
• Cations
• Nanogels
• Ribosome Inactivating Proteins, Type 1
• polyethylene glycol polyethyleneimine nanogel
• Polyethylene Glycols
• GEL protein, Gelonium multiflorum
• Polyethyleneimine
• Heparin

Topics

• Animals
• Apoptosis (genetics)
• Biocompatible Materials
• Cations
• Cell Line
• Female
• Gene Transfer Techniques
• Genetic Therapy (methods)
• Heparin (administration & dosage, chemistry)
• Humans
• Mice, Inbred BALB C
• Mice, Nude
• Nanogels
• Ovarian Neoplasms (pathology, therapy)
• Polyethylene Glycols (administration & dosage, chemistry, toxicity)
• Polyethyleneimine (administration & dosage, chemistry, toxicity)
• Ribosome Inactivating Proteins, Type 1 (administration & dosage, genetics, pharmacology)
• Xenograft Model Antitumor Assays